July 2024



The Cure Alzheimer’s Fund 2023 Annual Report is Now Available

2023 marked our 19th consecutive year of record-breaking results for contributions raised to fund research into Alzheimer’s disease totaling $34.9 million and distribution of research grants totaling $27.8 million. This year, our report is available in its entirety as well as in segments. To access each segment, click on the title and you will link to the page on CureAlz.org.

If you prefer, you can read the entire report here. If you would like to receive a printed copy of the full 2023 Annual Report, please send a note to [email protected] and include your full name and mailing address. Thank you.

 

Read the Annual Report


The FDA Approves KisunlaTM for Early Symptomatic Alzheimer’s Disease

On July 2, the FDA approved donanemab for the treatment of early symptomatic Alzheimer’s disease. Eli Lilly’s new once monthly IV infusion will be sold under the brand name KisunlaTM. Additional information about KisunlaTM and its approval is available on the CureAlz website.

Find Out More


We Are Proud of Our Diversified Research Funding Portfolio!

Since our founding, we have believed that it is essential – critical! – to provide funding to a broad range of scientific theory and discovery, and as detailed in our annual report, this continues to be a cornerstone of our non-profit. The newly approved anti-amyloid drugs encourage us to continue to support research aimed at better targeting this pathology, along with other aspects of Alzheimer’s disease. In 2023, we provided grants to investigations of tau, inflammation and the role of immune cells, genetics, the microbiome, lifestyle including exercise, diet, sleep, and stress, and many other areas.

We are the funder that our exceptional and passionate researchers turn to for support of the unconventional ideas that will become new extraordinary contributions to the understanding of the disease; we and they are deeply grateful to the generosity of our donors that makes these leaps forward possible. We are excited to see what our researchers discover in the broad range of projects we are funding in 2024 and for the future therapies enabled by these discoveries.

 


Thank You for Your Generosity

Today, 6.9 million people in the United States are living with a diagnosis of Alzheimer’s disease. Your gifts have enabled Cure Alzheimer’s Fund to support researchers who are relentless in their desire to understand Alzheimer’s disease. New information is emerging every day and there is great momentum in the field, but so much more to learn and discover.

100% of all general donations go to support our research and your gift will contribute to this progress so that we may realize a world without Alzheimer’s disease. If you recently made a donation to Cure Alzheimer’s Fund, thank you. If not, please consider making a gift today. 

Thank you.

Donate

 

—The Cure Alzheimer’s Fund Team